Glutathione depletion enhances arsenic trioxide-induced apoptosis in lymphoma cells through mitochondrial-independent mechanisms.
Bhalla
Savita
S
Gordon
Leo I
LI
David
Kevin
K
Prachand
Sheila
S
Singh
Amareshwar T K
AT
Yang
Shuo
S
Winter
Jane N
JN
Guo
Dongsheng
D
O'Halloran
Thomas
T
Platanias
Leonidas C
LC
Evens
Andrew M
AM
D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000494:pharmacology*; D005978:Glutathione / Q000502:physiology*; D006801:Humans; D008223:Lymphoma / Q000473:pathology*; D008928:Mitochondria / Q000502:physiology; D010087:Oxides / Q000494:pharmacology*
D000970:Antineoplastic Agents; D001152:Arsenicals; D010087:Oxides; D005978:Glutathione; D000077237:Arsenic Trioxide
Blood. 1999 Jan 1;93(1):268-77
9864170
Clin Cancer Res. 2002 Feb;8(2):566-72
11839678
Mol Cancer Ther. 2009 Jul;8(7):1955-63
19567824
Apoptosis. 2002 Jun;7(3):209-15
11997664
J Natl Cancer Inst. 1999 May 5;91(9):772-8
10328107
Cancer Res. 2002 Jul 15;62(14):3893-903
12124315
Leukemia. 2003 May;17(5):931-40
12750708
Blood. 2005 Feb 1;105(3):1265-73
15388578
Blood. 2006 Mar 15;107(6):2501-6
16291594
Leukemia. 2008 Oct;22(10):1853-63
18633430
Leuk Res. 2004 Sep;28(9):891-900
15234563
Clin Cancer Res. 2009 Jul 15;15(14):4769-76
19584162
Blood. 1999 Sep 15;94(6):2102-11
10477740